Key Points
- Insider sold: Director Lisa Miller sold 57,240 shares on Nov. 21 at an average of $6.43 for $368,053.20, reducing her position by 17.97% to 261,292 shares (~$1.68M), according to an SEC filing.
- Mixed fundamentals: LifeStance beat Q3 EPS estimates ($0.02 vs. -$0.01) and revenue rose 16.3% YoY to $363.8M, but the company still posts a negative net margin and ROE; the stock trades around $6.63 with a $2.58B market cap and a 12‑month range of $3.74–$8.30.
- Analyst stance and ownership: Analysts are mixed but the consensus is a "Moderate Buy" with a $9.00 target, and institutional investors own roughly 85.5% of the shares.
LifeStance Health Group, Inc. (NASDAQ:LFST - Get Free Report) insider Lisa Miller sold 57,240 shares of the business's stock in a transaction that occurred on Friday, November 21st. The shares were sold at an average price of $6.43, for a total transaction of $368,053.20. Following the transaction, the insider owned 261,292 shares of the company's stock, valued at approximately $1,680,107.56. This represents a 17.97% decrease in their position. The sale was disclosed in a document filed with the SEC, which is accessible through the SEC website.
LifeStance Health Group Trading Up 2.2%
LFST opened at $6.63 on Wednesday. The firm's fifty day moving average is $5.54 and its two-hundred day moving average is $5.26. The firm has a market cap of $2.58 billion, a PE ratio of -221.00 and a beta of 1.15. LifeStance Health Group, Inc. has a twelve month low of $3.74 and a twelve month high of $8.30. The company has a debt-to-equity ratio of 0.18, a quick ratio of 1.58 and a current ratio of 1.58.
LifeStance Health Group (NASDAQ:LFST - Get Free Report) last announced its quarterly earnings results on Thursday, November 6th. The company reported $0.02 earnings per share (EPS) for the quarter, beating the consensus estimate of ($0.01) by $0.03. LifeStance Health Group had a negative net margin of 0.67% and a negative return on equity of 0.62%. The company had revenue of $363.81 million during the quarter, compared to analyst estimates of $355.06 million. During the same quarter in the previous year, the business earned ($0.02) EPS. The firm's revenue was up 16.3% on a year-over-year basis. LifeStance Health Group has set its Q4 2025 guidance at EPS. FY 2025 guidance at EPS. Equities research analysts anticipate that LifeStance Health Group, Inc. will post -0.18 EPS for the current year.
Analyst Ratings Changes
LFST has been the topic of a number of research analyst reports. BMO Capital Markets assumed coverage on LifeStance Health Group in a research report on Thursday, November 13th. They set an "outperform" rating and a $8.00 price target on the stock. Weiss Ratings reissued a "sell (d-)" rating on shares of LifeStance Health Group in a research note on Wednesday, November 19th. UBS Group lifted their price target on shares of LifeStance Health Group from $9.00 to $10.00 and gave the company a "buy" rating in a research note on Friday, November 7th. BTIG Research increased their price objective on shares of LifeStance Health Group from $8.00 to $9.00 and gave the stock a "buy" rating in a research report on Thursday, November 6th. Finally, Zacks Research cut shares of LifeStance Health Group from a "strong-buy" rating to a "hold" rating in a research report on Wednesday, November 5th. One equities research analyst has rated the stock with a Strong Buy rating, six have issued a Buy rating, one has given a Hold rating and one has issued a Sell rating to the company's stock. According to MarketBeat, LifeStance Health Group has an average rating of "Moderate Buy" and a consensus target price of $9.00.
Read Our Latest Report on LifeStance Health Group
Institutional Trading of LifeStance Health Group
A number of large investors have recently added to or reduced their stakes in the company. Bayesian Capital Management LP bought a new position in shares of LifeStance Health Group in the 2nd quarter valued at about $52,000. Park Edge Advisors LLC bought a new position in LifeStance Health Group during the second quarter worth about $52,000. Vanguard Personalized Indexing Management LLC acquired a new position in LifeStance Health Group during the third quarter worth approximately $72,000. Blair William & Co. IL acquired a new stake in shares of LifeStance Health Group in the second quarter valued at approximately $70,000. Finally, Public Employees Retirement System of Ohio bought a new position in shares of LifeStance Health Group during the 2nd quarter worth approximately $70,000. Institutional investors and hedge funds own 85.50% of the company's stock.
About LifeStance Health Group
(
Get Free Report)
LifeStance Health Group, Inc, through its subsidiaries, provides outpatient mental health services to children, adolescents, adults, and geriatrics in the United States. The company offers patients a suite of mental health services, including psychiatric evaluations and treatment, psychological, and neuropsychological testing, as well as individual, family, and group therapy.
Read More
This instant news alert was generated by narrative science technology and financial data from InsiderTrades.com in order to provide readers with the fastest and most accurate reporting. Please send any questions or comments about this story to [email protected].
